CARL T.C. GUTIERREZ GOVERNOR OF- GUAM JAØO48B The Honorable Antonio R. Unpingco Speaker Mina'Bente Kufittro na Liheslaturan Guåhan T wenty-Fourth Guam Legislature Guam Legislature Temporary Building 155 healer Street Hagåtña, Guam 96910 Dear Speaker Unpingco: Enclosed please find Substitute Bill No. 347 (COR), "AN ACT TO A D D CHAPTER 24 TO DIVISION 3 OF TITLE 17 OF THE GUAM CODE ANNOTATED, RELATIVE TO DESIGNATING UOG'S COMMITTEE ON HUMAN SUBJECTS IN RESEARCH AS THE INSTITUTIONAL REVIEW BOARD FOR REVIEW AND APPROVAL OF RESEARCH CONDUCTED ON GUAM WìTH REGARD TO HUMAN SUBJECTS", which was vetoed and subsequently overridden by i Liheslatura. This legislation is now designated as Public Law No. 2 4 - 3 2 6. Very truly yours, Car1 T. C. Gutierrez I Maga'lahen Guåhan Governor of Guam Attach ment: copy attached for signed bill or overridden bill original attached for vetoed bill cc: The Honorable Joanne M. S. Brown Legislative Secretary Ricardo I. Bordallc Governor’s Complex • Post Office Box 2950, Agana, Guam 96912 • (671)472-8931 • Fax (6Z1)4 77-GtJAv MINA'BENTE KUATTRO NA LIHESLATURAN GUAHAN 1998 (SECOND) Regular Session CERTIFICATION OF PASSAGE OF AN ACT TO I GA’LAHEN G LIAHAN This is to certify that Substitute Bill No. 347 (COR), “AN ACT TO ADD CHAPTER 24 TO DIVISION 3 OF TITLE 17 OF TI-IE GUAM CODE ANNOTATED, RELATIVE TO DESIGNATING UOG'S COMMITTEE ON HUMAN SUBJECTS IN RESEARCH AS THE INSTITUTIONAL REVIEW BOARD FOR REVIEW AND APPROVAL OF RESEARCH CONDUCTED ON GUAM WITH REGARD TO I-HUMAN SUBJECTS,” returned without approval of I Maga"lahen Gradx, was reconsidered by I Liheslaturan Cuahan and after such consideration, did agree, on the 30“ day of December, 1998, to pass said bill notwithstanding the veto of i Maga’lahen Citrix by a vote teen (14) members. Atteste ANNE M. WN enator and Legislative Secretary AN 0ON R. UNPINGCO Speaker Assistant Staff Officer Maga’lahi’s Office Public Law No. 2 4=32Q MINA’ BENTE KUATTnO NA LIHESLATURAN GUAHAN 1997 (First) Regular Session Bill No. 347 (COR) As substituted by the Committee on Education and as amended on the Floor Introduced by: L. A. Leon Guerrero W.B.S.M. Flores T. C. Ada F. B. Aguon, Jr. A. C. Blaz J.M.S. Brown Felix P. Camacho Francisco P. Camacho M. C. Charfauros E. J. Cruz Mark Forbes L. F. Kasperbauer A. C. Lamorena, V C. A. Leon Guerrero V. C. Pangelinan J. C. Salas A.L.G. Santos F. E. Santos A. R. Unpingco J. T. Won Pat AN ACT TO ADD CHAPTER 24 TO DIVISION 3 OF TITLE 17 OF THE GUAM CODE ANNOTATED, RELATIVE TO DESIGNATING UOG'S COMMITTEE ON HUMAN SUBJECTS IN RESEARCH AS THE INSTITUTIONAL REVIEW BOARD FOIt REVIEW AND APPROVAL OF RESEARCH CONDUCTED ON GUAM WITH REGARD TO HUMAN SUBJECTS. 1 BE IT ENACTED BY THE PEOPLE OF GUAM: 2 Section 1. Legislative Findings. Liheslaturan Guahan finds that 3 research studies involving human subjects are conducted on Guam, and 4 realizes a need to protect the rights of persons participating in human 5 research projects through a review of research proposals, plans, procedures 6 and protocols. It further finds that designation of the University of Guam’s 7 (“UOG's”) Committee on Human Subjects in Research as the InstitlltlOTlal 8 Review Board (“IRB”) for researchers and collaborators at University of Guam 9 and for researchers who are not under other IRB's is the appropriate body to 10 review proposals, plans, procedures and protocol for research involving 11 human subjects and to approve or disapprove the same. 12 Furthermore, I Liheslaturan Guahan finds that human research conducted 13 on Guam do Sof always acquire informed consent from persons participating 14 in the programs, and that there is a need to regulate and mandate informed 15 consents to ensure that those persons participating are adequately informed. 16 The Review Board will be under the auspices of UOG as it has been 17 identified as the suitable entity under the direction of the Graduate School 18 and Research Department. 19 Section 2. Chapter 24 is hereby added to Division 3 of Title 17 of the 20 Guam Code Annotated to read as follows: 21 “CHAPTER 24. 22 Section 24101. Definitions. As used in this Chapter: 23 (a) ’Board’ means the Guam Research Review Board. 2 1 (b) ’Investigator’ means any individual, public or private entity, 2 or agency engaged in or purposing to engage in research subject to 3 regulation. 4 (c) ’Legally’ authorized representative means an individual or 5 judicial or other body authorized under applicable law to consent on 6 behalf of a prospective subject to the subject's participation in the 7 procedure(s) involved in the research. 8 (d) ’Research’ as defined in the Federal Register, §102 9 Definitions. 10 (e) ’Research’ subject to regulation means research involving 11 human subjects. 12 (f) 'Human subjects’ means a living individual about whom an 13 investigator conducting research obtains: 14 (1) Data Through Intervention or Interaction with the 15 Individual. Intervention includes both physical 16 procedures by which data are gathered and manipulations of the 17 subject or the subject's environment that are performed for 18 research purposes. Interaction includes communication or 19 interpersonal contact between investigator and subject. 20 (2) Identifiable Private Information. Private irJormation 21 may include information about behavior that occurs in a context 22 in which an individual can reasonably expect that no observation 23 or recording is taking place, and information which has been 24 provided for specific purposes by an individual and which the 25 individual can reasonably expect will not be made public (for 3 1 example, medical records). Private information must be 2 individually identifiable in order for obtaining the information to 3 constitute research involving human subjects. 4 (g) 'Minimal risk’ means that the probability and magnitude of 5 harm or discomfort anticipated in the research are not greater in and of 6 themselves than those ordinarily encountered in daily Me or during the 7 performance of routine physical or psychological examination or tests. 8 Section 24102. Board; Terms; Appointment; Continuance; 9 Removal. Members of the Board shall be consistent with the 10 University of Guam’s Committee on Human Subjects and Research 11 which is: three (3) or four (4) professional research proficient experts 12 from the Urñversity of Guam; at least one (1) Guam commurñty 13 representative; at least one (1) local religious leader; and at least one (1) 14 licensed practlcing local medical doctor. 15 Section 24103. Purpose. The purpose of the Board is to 16 review, approve, require modifications to secure approval or 17 disapprove all research subject to regulation. 18 Section 24104. Powers. The Board shall have and exerclse 19 each and all of the following powers: 20 (a) review and have authority to approve, requlre 21 modifications to secure approval or disapprove all research 22 activities covered by the rules and regulations; 23 (b) require documentation of informed consent of all 24 human subjects participating in the research subject to regulation. 25 At the Board’s discretion, require additional irdormation be given 4 1 to the subjects which would add to the protection of the rights and 2 welfare of the subjects; 3 (c) notify the investigators and the institution in writing 4 of its decision to approve or disapprove the proposed research 5 activity, or of modifications required to secure approval of the 6 research activity. If the Board decides to disapprove a research 7 activity, it shall include in its written notification a statement of 8 the reasons for lts decision and give the investigator an 9 opportunity to respond in person or in writing; 10 (d) conduct continuing review of research subject to 11 regulation at intervals appropriate to the degree of risk, but not 12 less than once per year and shall have authority to observe or have 13 a third party observe and consent to the process and the research; 14 and 15 (e) to disapprove research subject to regulation which had 16 been previously approved. 17 Section 24105. Duties of Investigators. The 18 proposals, plans, procedures and protocols for all proposed research 19 subject to regulation shall be submitted to the Board for review, 20 approval, modification or dlsapproval. No research subject to 21 regulation shall be conducted without Board approval. The plans, 22 procedures and protocols for all research subject to regulation which is 23 being conducted at the time of the enactment of this legislation shall be 24 submitted to the Board for review, approval, modification or 25 disapproval within thirty (30) days of this bill becoming law. Research i subject to regulation which is being conducted at the time of the 2 enactment or this legislation may continue pending Board action. 3 Section 24106. General Requirements for Informed Consent. 4 No investigator may involve a human being in research subject to 5 regulation unless the investigator has obtained the legally effective 6 informed consent of the subject, or the subject's legally authorized 7 representative. An investigator shall seek such consent only under 8 circumstances that provide the prospective subject or the representative 9 sufficient opporturñty to consider whether or not to participate, and that 10 minimize the possibility of coercion or undue irifluence. The 11 information that is given to the subject or the representative shall be in 12 language understandable to the subject or the representative. Unless 13 otherwise provided by law or regulation, no informed consent, whether 14 oral or written, may include any exculpatory language through which 15 the subject or the representative is made to waive or appear to waive 16 any of the subject’s legal rights, or releases or appears to release the 17 investigator, the research sponsor, if different, or their agents from 18 liability for negligence. 19 (a) Basic Elements of Informed Consent. Except as 20 provided in Paragraphs (c) or (d) of this Section, in seeking 21 informed consent the following information shall be provided to 22 each human subject or the subject's legally authorized 23 representative: 24 (1) a statement that the study involves research, an 25 explanation of the purpose of the research and the expected 6 1 duration of the subject’s participation, description of the 2 procedures to be followed and identification of any 3 procedures which are experimental; 4 (2) a description of any reasonably foreseeable risk 5 or discomforts to the subject; 6 (3) a description of any benefits to the subject or to 7 others which may reasonably be expected from the research; 8 (4) a disclosure of appropriate alternative 9 procedures or courses or treatment, if any, that might be 10 advantageous to the subject; 11 (5) a statement describing the extent, if any, to 12 which confidentiality of records identifying the subject will 13 be maintained; 14 (6) for research involving more than minimal risk, 15 an explanation as to whether any compensation and an 16 explanation as to whether any medical treatments are 17 available if injury occurs, and, if so, what it consists of or 18 whether further information may be obtained; 19 (7) an explanation of whom to contact for answers 20 to pertinent questions about the research and research 21 subject’s rights, and whom to contact in the event of a 22 research-related injury to the subject; and 23 (8) a statement that participation is voluntary, 24 refusal to participate will involve no penalty or loss of '5 benefits to which the subject is otherwise entitled, and the 7 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 -'5 subject may discontinue participation at any time without penalty OF lOsS of benefits to which the subject is otherwise entitled. (b) Additional Elements of Informed Consent. When appropriate, the Board may require that one (1) or more of the following elements of information shall also be provided to each subject: (1) a statement that the particular treatment or procedure may involve risks to the subject, or to the embryo or fetus, if the subject is or may become pregnant, which are currently urrforeseeable; (2) anticipated circumstances under which the subject's participation may be terminated by an investigator without regard to the subject’s consent; (3) any additional cost to the subject that may result from participation in the research; (4) the consequences of a subject's decision to withdraw from the research and procedures for orderly termination of participation by the subject; (5) a statement that significant new findings developed during the course of the research which may relate to the subject's willingness to continue participation will be provided to the subject; and (6) the approximate number of subjects involved in the study. 8 i (c) The Board may approve a consent procedure which 2 does not include, or which alters, some or all of the elements of 3 irdormed consent set forth above, or waive the requirements to 4 obtain informed consent; provided, that the Board finds and 5 documents that: 6 (1) the research or demonstration project is to be 7 conducted by, or subject to, the approval of Federal, state, 8 territorial or local government officials, and is designed to 9 study, evaluate or otherwise examine: (i) public benefit of 10 service programs; (ii) procedures for obtaining benefits or 11 services under those programs; (iii) possible changes and/ or 12 alternatives to those programs or procedures; or (iv) possible 13 changes in methods or levels of payments for benefits or 14 services under those programs; and 15 (2) the research could not practically be carried out 16 without the waiver or alteration. 17 (d) The Board may approve a consent procedure which 18 does not include, or which alters, some or all of the elements of 19 informed consent set forth in this Section, or waives the 20 requirements to obtain informed consent; provided, that the Board 21 finds and documents that: 22 (1) the research involves no more than minimal risk 23 to the subject; 24 (2) the walver or alteration will nof adversely affect 25 the rights and welfare of the subject; 9 1 (3) the research could not practically be carried out 2 without the waiver or alteration; and 3 (4) whenever appropriate, the subjects will be 4 provided with additional and pertinent information after 5 participation. 6 (e) The informed consent requirements are not intended to 7 preempt any applicable Federal, state or local laws which require 8 additional information to be disclosed in order for informed 9 consent to be legally effective. 10 (9 Nothing in this Section is intended to limit the 11 authority of a physician to provide emergency medical care, to the 12 extent the physician is permitted to do so under applicable 13 Federal, state, or territorial law. 14 Section 24107. Criteria for Board Approval of Research. 15 In order to approve research subject to regulation, the Board shall 16 determine that all the following requirements are satisfied: 17 (a) Risks to subject are minimized: (i) by using 18 procedures which are consistent with sound research design and 19 which do nof unnecessarily expose subject’s to rlsk; and (ii) 20 whenever appropriate by using procedures akeady being 21 performed on the subjects for diagnostic or treatment purposes. 22 (b) Risks to subject are reasonable in relation to 23 anticipated benefits, if any, to subjects and the importance of the 24 knowledge that may reasonably be expected to result. In 25 evaluating risks and beneflts, the Board should consider only 10 those risks and benefits that may result from the research, as 2 distinguished from risks and benefits of therapies subject would 3 receive even if not participating in the research. The Board should 4 not consider possible long range effects of applying knowledge 5 gained in the research (for example, the possible effects of the 6 research on public policy) as among those research risks that fall 7 within the purview of lts responsibility. 8 (c) Selection of the subjects is equitable. In making this 9 assessment the Board should take into account the purposes of the 10 research and the setting in which the research would be 11 conducted and should be particularly cognizant of the special 12 problems that research involving vulnerable populations, such as 13 children, prisoners, pregnant woman, persons with dlsabilities, 14 the elderly, or economically or educationally disadvantaged 15 persons. 16 (d) Informed consent will be sought from each 17 prospective subject or the subject’s legally authorized 18 representative, in accordance with, and to the extent required by 19 Board regulation. 20 (e) lrdormed consent will be appropriately documented, 21 in accordance with, and to the extent required by Board 22 regulation. 23 ( When appropriate, the research plan makes adequate 24 provision for monitoring the data collected to ensure the safety of 25 subjects. 1 (g) When appropriate, there are adequate provisions to 2 protect the privacy of subjects and to maintain the confidentiality 3 of data. 4 When some or all of the subjects are likely to be vulnerable 5 to coercion or undue influence, such as children, the elderly, 6 prisoners, pregnant women, mentally disabled persons or 7 economically or educatiOnally disadvantaged persons, additional 8 safeguards have been included in the research plans, procedures 9 or protocols to protect the rights and welfare of these subjects. 10 (h) Progress reports or thesis shall be made available to 11 subjects participating in the research as appropriate. 12 Section 24108. Grievance Procedure. lf application for 13 approval is denied for a research proposal, investigators may appeal to 14 the Dean of the Graduate School and Research. The Dean will appoint 15 an ad hoc committee for a second, independent review of the research 16 project. The findings of the ad hoc committee are to be presented to the 17 Committee on Human Subjects in Research no later than ninety (90) 18 days after receipt of grievance from the investigator, to determine the 19 final decision to approve or not to approve a research project. 20 Section 24109. Fines and Penalties. Upon determination of 21 the Review Board through the approved rules and regulations, any 22 investigator, research sponsor or their agents, which conducts research 23 subject to regulation in violation of this Chapter shall be subject to a fine 24 of One Thousand Dollars ($1,000.00) per each violation, and shall be 12 1 prohibited from continuing and conducting human research studies for 2 not less than two (2) years. 3 The Dean of the Graduate School and Research shall refer any 4 cases determined by the Review Board as a valid violation to the 5 Attorney General's Office for investigation and prosecution. 6 Section 24110. Appropriation: Authorization. There is 7 hereby appropriated from the General Fund a total of Forty Thousand 8 Dollars ($40,000.00) for the purpose of hiring one (1) clerical staff and 9 other accommodations necessary to assist with the function of 10 processing applications. This appropriation shall continue until 11 expended for the operations and purposes specified herein.” 13 Tw ñHTY YOU Ft4 , UAN PEG ISLATURE COMMITTEE OU Eii cATIOts La*vzence F. Kasperbauer c1 r*' Senator Sal as UnpiNgCO Menu:or ThomasC. Ana "enatc r Franh B. Aguon he' a to r Elizabeth Barrett- Aiiaerson Vice peaker JoaoneM.S. Senaor feHxé CamacBo CamacHo Ed wardo d. ForDes Angel L.G. Santos Judith ifon Pat- Borja October 22, 1998 The Honorable Antonio R. Unpingco Speaker, 24t h te am Legislature Hagdtña, Guam via: Committee on Rules Dear Mr. Speaker: The Committee on Education to which was referred Bill No. 347 (COR): “AN ACT TO ADD CHAPTER 24, DIYISION 3. 17 GCC TO DEST GNA I E THE UT 1’.'*P-3IT Y OF Gt.'AM’S COM4IITTEE OH riMlLN SUEJ*C'TS P? RESFARCI-I IS THE INSTITUTIONAL REVIEIV BOARD FOR REVIEW AND APPROVAL OI RSA ?vFxCH CONDUCTED ON GUAM \VIT1I REGARD TO HU4IAN back u’ith the recommendation TO DO PASS Substitute Bill No. 347. Votes of the committee members are as follows: 7 To Pass Not To Pass To The Inactive File Abstained /\tiachmen ts Education is the lYayl TWEMTY-hOUKl. CUAM LkGISLATURZ COMMITTEE ON EDUCATION Se o etor Lawrence F. Kasperbauer October 22, 1998 Se I-'at O r Jonn C. Sat as Antonio R. TO: All Members Committee on Education Se n ato r FROM: Chairman SUBJ: Voting Sheet Senate r Aguon £liznbetn Barrett- Anderson face Speul ^* ñ‹ ‹›?,iiized by his pecrs in one w ay or anotliei’ nn' ltte assistants vl r* o idc so-called leg v ork for the researcher. The real benefactors arc 1)1OS £ is hose qualilJ of lii iiig will be made bettcr by such a disct4\ cry and the young i1i‹jtiisitive minds who will push off from where WC I C‹It c, either to affirms or hegaie eat findings. The scholars and stakeholders in this deliberatlon today must then, recognize that it is' the community at large and humanity in general who would benefit from the results. l8 ordei to do this we must all safeguard the quality of researches performed here and that they be done in the strictest ethical standards that show respect to those people without whom wc will not be able to conduct our studies. This bill will objectify what some of us are doing in the nance of “Research”. It will make us accountable for what we do in its name and will enforce the standards that are recognized most anywhere else. Thank you for your kind attention. Gregoria Smith Community Psychologist Tel/ Fax ti49 7571 o AERSMYOFGUAM “ 1 BETSEDAT U H oiveiox or scCxOxLaLuEaGxEnxOvFioARTS &scSiECIfElcNcCsESa socs wonx TeTepNOl (07J) 735-2870 FW {6 '1) Kg rsou: The Fiono/able La\•tence F. ffaaperbayer Senator. Chair. 6ég\mt¥ee on Education Dr. Maiozs C. Ty«„AssL Professor, Psychology PHouS University df Gvc 'i Dr. Mary L Spec, Dean. College ofAns A S‹ñennee, UOG 671-475-2000 ‘. 8Tt7 25f Or. u8a-Katñpa Or¥ig. Chad. Committee on Human Research Subjects, UOG Bill No. 347, An Ais to Create a Revie\y Board fa Reviaw ond Approval of Research Cond‹zctgd on Guam with Regerd!to Human Subjects essage• , ' ! ' Dear Seriatpr Ka*p&bauer, . ‘ ’ “* . I write to urge you a lobby against Bill No. 347. I am a faculty mem6er of the University of Guam wbere i I am engaged in an activé program of research, as are many of my colleagues. Research is of ina•lnsic benefit té the commune (both here on Guam and elsewhcreJ and directly helps student learning. I take pridé in the Su *f 'r'rés aich that is being fostwed at the University of Guam and am puzzled by Bifl No. 347. The spirit ofth#. bifl'is fully appropriatwit is irdeed important to be concernaJ first far tke welfare of human subjects. gmt to pr.ott•ts human.subj what is puzzling to me is the need fo' sucb a i ! bill; es etaally one that danstralns research done at the University, since UOG already has a review process that very carefull:y monitor research. Some of the many reasons against this bill include: ,' \. Such a law would be largely unjsecedented. Virtually all jurisdictions in the US and many o countries allow universiii@ and hospiBls to administer research internally. Indeed; UOG alieady has , an excelldnt instizuttonal. review panel, the Committee on f4uman Research Subjects. 2. Even the proposal of such a law is disturbing as it gives the appearance that our island’s govenment: (ails to understand (ñn,d japs fails zo value) research and the University. committee 4. The passage of such.q law Auld swipusly undermine the eParts of faculty to bring in research money, Which traditionally ñelps stlpport the lost institution. It also adds to.Guam’s already large bureauoacy. ' Thank you for your tims end your effons in ensuring thac this bill does not oass, o- at the very least ‹o. inane sure the bill is amen ded,to exempt any researdi conducted on Guam that ‹eceives approva( from UOG's existing internal C ?nmisee on F uman Research Subjects T0T9L P. 01 Defînitions Raaaaæh n›aane a imæô$ation, indrding raceamh development, testirig and æaluat›on, des ned to or œntñbuta æ eabb Raaaarah subted to reqylaéon encompass those research aoi¥ities lbr which a f¥deral department or agency has specific recporaibiity for regulating as a research a¢tMty. It does not include re6earcfj actMtbs whiQi are ir¥fidentally regubtnd by a federal deparbnent or agency sdely as part of the depar¥nent's or agency's broader responsibility to regulate certain types of activitBs whatfer faseaich or non-research m nature (e.g., Waga/Hour fequi/ements Human suh]aotrfieans a flVirig individual about whom an irnestigator (whether professional or students coriducgng researdl olzlaxis (1) data through intervenron or interaction with the indfvtduaI, or (2) identfffable private information. Minimal fisk means that the probability and magnitude of harm or discomfort anécipatadin tha research are not greater in arid of themselves than those ordinarily encountered in daily life or duñng the performanm of rouine physical or psychological exarninarorn or tests. Cerffffcadon means the oflïcial notîÏîœtion by the institution tg the suppoitirig depar¥mnt or agancy, in acœidanœ with the reguiremerits ofthis polîcy, that a reseerÖj project or actfvity involving human subjeÖs has been ravîewed ard approvæl by an IRB in accordanca with an approved aesuranœ. Purpose The CHRS evaluates the level of risk to human subjects, ‹ecommends procedural steps to minimize risk9, and provides certification as needed by 0›e researcher. It does not judge research design nor recommend methodological alternatives. Under federal regulations, the CHRS is charged with safeguarding the rights and wellbre of humans involved, and must determine: • whe0ier öle nghte and woffaæ of the humane involved in research will be adequately protacted, and • wfiather legally affbcth/e infbfmed conaent of gll humane to be eollcitad will be obtained with adequate reCorde maintained (request CHR6 Informed Content Guidelines, Form B and C). Prccedures 1. Obtain an appliméon fix CHRS review (Form A) lion tf›e UOG O8‹a of t›e G/aduata School and Research. lnclt¥Ja copies eg 6s pr0jaO pRzpoBal, ag consent forms, and gummary sajpts of varbal and/or video instrudbns to ba depleted to sub}ecB. 2. Maintaif\ worI‹ing contad with the CHRS Ckair during the review process, and provde supplemental infbrmaéon as requesBd by the -nmidno or stAu\it a feplytD $ugpe9ted ¢x›nsaetations. 3. If approVed, rœeœÖ\ pfajeds may Iæ monb ad by One CHRS æ nædal to ensure due process and Appendix o UNIVERSITY OF GUAM Committee on Human Research Subjects Office of the Graduate School and Research RESEARCH SUBJECT’S BILL OF RIGHTS Any person who is requested to consent to participate as a subject in a research project, or who is requested to consent on behalf of another, has the right to: 1. Be informed of the nature and purpose of the experiment. 2. Be given an explanation of the procedures to be followed in the research study, and drugs or device to be used. 3. Be given a description of any possible discomfort and risks reasonably to be expected from a research procedure, if applicable. 4. Be given an explanation of any benefits to the subject reasonably to be expected from the research procedure, if applicable. 5. Be given a disclosure of any appropriate alternative procedures, drugs, or devices that might be advantages to the subject, and their relative riiks and benefits. 6. Be informed of the avenues of medical treatment, if any, available to the subject after the experiment if complications should arise. 7. Be given an opportunity to ask any questions concerning the experiment or the procedures involved. 8. Be instructed that consent to participate in the research study may be withdrawn at any time, and the subject may discontinue participation in the research study without prejudice. 9. Be given a copy of a signed and dated written consent form when one is required. 10. Be given the opportunity to decide to consent or not to consent to participate in a research study without the intervention of any element of force, fraud, deceit, duress, coercion, or undue influence on the subject’s decision. If you have a question regarding the research study, the researcher or other research personnel will be glad to answer them. You may seek information from the UOG Committee for Human Research Subjects—established for the protection of participants in research projects—by calling 735-2173 (UOG Graduate School & Research) from 8 am to 5 pm, Monday through Friday, or by writing to the above address. LWRapxHorRAz* Iotbetrwork-rstain‹Iactivitinc,ps élogistsrccpct tbnrightsofoth‹ssuzbaIdyabics,a0iu•d•c, aPiai«*¥t*•l zrfzom tbczr II) XOQ¥ls¢ZtAñndtiOn to tbcir wozk•ccIazcd activitisc. jn ogist• d* no* mgagc ia uafatr dt¥cztistinatizsl baBcd oo ggndgf, dbaicity, naziazd origg rali8ioo, mud " takon. dI*- abifity,zocirxxx›naazicstuus,or•aybactz h7k•'• L11 S••••* Barassa«at (a)PcyckoIogisudozzotozga$sta bazaua›ant Smud barassa›s lx zKactim wazld v gato tlzb gttt¡cs 40d stealsB• szzBf•xoiz’ ’” ''=•’ •=w• UNfVZR9fTY OF G£tÆM UNIBE¥9Ü@AT GUANAN mæænzsœæaacgszææczs TO: Principal Invastigato‹s/Researcher at UOG FROM: UOG Committee on Human Research Subjects (CHRS) SUBJECT: Institutional Reytew Assuring Human Rights of Subjects This memo descrlbes poBsy and æview ctf\arîa for O'ie protection of human subjects involyed in projects œnductad at, aPonaored by, or aI'/iliated with the University of Guam, regardless of the absenœ or prœenœ of support, and ægardless of who elæ may have rm/iewed jfiern. Research projets (whether ptolëssional g¿_gggjggg Oiat obtain (a) data through infsîactian with irdiyîduaB, or (b) identifiable pñvate informaëon are subject to review. ÆI such projeœ must feœive pñor exemption or approæl fiom the CHRS, which sewes as gie University’s lnsëtuëonal Reyiew Boaid in œmplianœ with fedeial policy eatabliahed by the U.S. Oflîœ of Söenœ and Technology. Your understanding of thèse regulations is important for the Unh/eisity's adhereriæ to fsdeial policy on this topic, and for your own fiabilité assumed in the pæformanœ ofreseamh and #aining prof Each of thèse federal deparbnenfs and agencjes have adopted ö›ese regulations for the protection of human subjects irivoI›/ed in research œnducted or funded by the following: US Department of Agñadture; Department of Ene‹gy; National Aeronautics and Space Administraëon; Departmœt of Commerce; Consurner P‹odud Safety Commission; International Development Coopera0on Agericy; Agency for International Deælopment; Department of Housing and Urban Development; Deparbnent of Justice; Deparbnent of , Department of Eduœtion; Department of Vejgian Alfaiæ; Environmental Protection Agency; National Scienœ Foundatlan; Department of Health and Human Seiviœs; Deparbnent of Transponalfon. Researchers should be awaæ of other regional æview boards in addition to Elle Unfærsity CHRS. The Guazi Memorial Hospital has an IRB for mœliœl æsearch on Guam.” Alao, permit reyiews are æquired by tf›e Fæjerajed Statæ of Mioonesia, with similar législation being œnsdered by othœ Paöfîc laland entitles. The FSM has an eslablished deaiinghouse pioceduæ Jbr anyone p«›posing ræearch in the areas of atchaeoloqy, oial histDry, SoÔaI CLlltufe, Œ/stDm, arls/cfalfs, afŒliyal, political histDfy, or anything to do with hietoric and culturat resounæs in the FSM. To what does this policy apply† Uni /ersity policy applies to all ‹eaærŒ iwoNing human subjects œnducted, supported or o0›etwiæ subject to ægulaton by any federal department or aqency whidi takes appfopñate adminisbaöve action to make the policy applkable to suŒ research. lt also indudœ ‹œeaia œnduÖed, supported, or otherwise subject to regulalton by the federal govemrnent outside the United States. Research If›at is neîlher œnduöed nor suppo‹ted by a fède‹al deparbnent or agency but is subject to regulation must be /eyiewed and appnwed by an instîtutional /eview board (IRB) 0›at operales in aa›o‹danos with the peitinœt ‹equî‹ements ofbiis policy. Unless otherwise required, /eseatch actñ/iges wheie One only in ‹olvement of human subjects will be in one or more of the fdlowing ‹ategories may be ezemptad or subjected only to expedited reyiew prooedures as assessed from ‹he CHRS Reyiew Application: (1) Research œnduond in establîdæd or commonly accepted eduœtîanal Settings, involving normal eduætîonal practî‹æs, such as (i) research on regular and apeôal eduœtion instrucôonal etrategîœ, or (ii) æseatoi on the eflbcbæneœ ofor the œmparîson among insbucêonal techniques, artîcula, or ciaasmom management rnethods. (2) Research involving the uee of eduæôonal taets (cognitive, &ægriostic, aptitude, - ›hîevernent), sun/ey ptoœduæs or obseræêon of public behavÔr, unleæ: (i) Irtfonœtîon obtained ia æœrded in such a manner Oæt human subjects can be dentilted, diieclfty or through dîdeennttiî55eerrs linked to the esub{edz; and gi) any diacbsuæ of the human subjects’ responses outside the ould taasonably place the subjects at ñsk of cittiinal or civil febility or be damaging to the subjects’ financial (3)ResemhndsæmWundwpsœgmPh2dRüeœRq1(#æ#aÆeœëœÆdor appointed public oflîcials or mndidatea for public oflîce; or (i) fedeial statele(s) information will be maîmained thtoughout tlæ æsearch and thereañer. (4) Research involvîng the oolbctian or study of exîetîng data, dœxnerits, records. pathologîœl speörnens, or &ægnostîc specà'neiæ, if 0›eee eounæs are publîcly æailable or ifthe information is recordaf by0is itweati$ator in auofi a manner Oiat su#jéc/s cannot be kfentilied, directly or Oirough identifiers linked to tta subs (5) Research and demonslratbn pro}ecB which aia designed to study, evaluate or otherwise examine: #) Public beneE or ser¥ica pto$tams; (g) ptocedurea for obtaining benefits or eenfioae under Oiæe progærna; (A) poesble dænges in or alBmatîves to those p‹ogæms; or (iv) possible changea in methods, payment or senñces under thoee (6) Taste and food quality evaluation and consumer aaxplarice sbzdie8, (i) if wholesome foods without addîtîves an œneumed or §§ ifa food is œnsumed that œntains a food ingredîent at or bebw the Iesel and for a usa Jöund æ be safe, or agñcultuæl chemiœl or eiwironmental œri/aminant at or below gie lœel Iôund to be aafe, by the Food and Drug Adminia#atîon orappioved bythe Eiwironmental Protection Agency orthe Food Safaty and Inspectbn Service ofgie USDA. 8actioo i03 Assuring compliance Pitt this policy--research corductad or supported by aoy federal department or ageocy. (a) Each institution engaged in research which is covered by this policy and which is conducted or supported by a federal department or agency shall provide written assurance satisfactory to the department or agency head that it will comply witA the requirements set forth in this policy. In lieu of requiring submission of an assurance, appropriate for the research in question, on file with the Office for Protection from Research Risks, RHS, and approved for federal wide use by that office. (b) Departments and agencies will conduct or support researeA covered by this policy pnly if the institution has an assurance approvea aa provided by this section, and only t§ the institution chas lfled co The departztene or agency head thai I:he research has been reviewed and approved by an xRB provided for in the assurance, and will be subject to continuing review by the IRB. Assurances applicable to federally supported or conducted research shall at a minimum include: (1) A statement ofprincipals governing the institution in the discharge of its responsibilities for protecting the rights and welfare of human subjects of research conducted at or sponsored by tAe institution, reqardlpss o w et e the peseqpch js subject to federql peoulation. (2) Designation of one or more IRBs estab1iah•d in accordance with the requirements of this policy, and for which provisions are made for peetiqg space and suf#iciept staf#„tp suDoort the IRB•s review and record keeDino duties. (3) L list of IRB members identified by name, earned degrees, representative capacity; . . . . sufficient to describe each members chief anticipated contributions . . . (4) Written procedures which the IRB will follow . . . (5) Written procedures for ensuring prompt reporting to the IRB, appropriate institutional officials, and the department or agency head of (1) any unanticipated problems involving risks to subjects or others or any serious or continuing noncompliance with this policy or the requirements or determinations of the IRB and (ii) any suspension or termination of IRB approval. (c) to (g) [additional specifications and policy for assurances] (f) . . . Institutions UithOUt an approved assurance covering the research ahall certify within 3o days after receipt of a request for such a certification from the department or agency, that the application or proposal has been approved by the IRB. If the sact1on 1o2 De€1a1€1ons (a) Department or agency head . . . (b) Institution . . . (d) Hesearcfl means a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge. (e) Aesearcb subject to regu2atlon, . . . encompass those research activities for which a federal department or agency has specific responsibility for regulating as a research activity. It does not include research activities which are incidentally regulated by a federal department or agency solely as part of the department's or agency's broader responsibility to regulate certain types of activities whether research or non-research in nature (e.g., Wage and Hour requirements administered by the Department of Labor). (f) Buman subject means a living individual about whom an investigator (whether professional pr student) conducting research obtains (1) data through intervention or interaction with the individual, or (2) identifiable private information. (]xterventlon and private information are given expanded definition) (h) IRB appz-ova-I ... (i) Blzimal rlsk means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. (j) Certification means the official notification by the institution to the supporting department or agency, in accordance with the requirements of this policy, that a research project or activity involvinghuman subjects has been reviewed and approved by an IRB in accordance with an approved assurance. 3 (b) Unless otherwise required . . . research activities in which the only involvement of human subjects will be in one or more of the foLloWing categories are exempt from this policy: (1) Research conducted in established or commonly accepted educational settings, involving normal educational practices, such as (i) research On regular and special education instructional strategies, or (ii) research on the effectiveness oY or the comparison among instructional techniques, curricula, or classroom management methods. (2) Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures or observation of public behavior, unless: (i) Information obtained is recorded in such a manner that human subjects can be iaent:if1e‹t, directly or through identifiers linked to the subjects; and (ii) any disclosure of the human subjects' responses outside the research could reasonably place the subjects at risk of criminal or civil liability or be damaging tO the subjects' financial standing, employability, or reputation. (3) Research [under 101(b)(2)] that is not exempt under paragraph (b)(2) of this section, if: (i) ... subjects are elected or appointed public officials or candidates for public office; or (ii) federal statute(s) require(s) without exception that the confidentiality of the personally identifiable information will be maintained throughout the research and thereafter. (4) Research, involving the collection or study Of existing data, documents, records, pathological specimens, or diagnostic specimens, if these sources are publicly available or if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects. (5) Research and demonstration projects... which are designed to study, evaluate or otherwise examine: (i) Public benefit or service programs; (ii) procedures for obtaining benefits or services under those programs; (iii) possible changes in or alternatives to those programs ...(iv) possible changes in methods or ... payment ... or services under those programs. (6) Taste and food quality evaluation and consumer acceptance studies, (i) if wholesome foods without additives are consumed or (ii) if a food is consumed that contains a food ingredient at or below the level and for a use found to be safe, or agricultural chsrical or environmental contaminant at or below the level found to be aafe, by the Food and Drug Administration or approved by the Environmental Protection Agency or the Food Safety and Inspection Service of the USDA. 2 UxSVBeszzg or auazg tJDlBsKsBaAz ouaanx COMMITTEE on IlTJhfWf RZSZAItCIE SUBJECTS RESEARCH COUNCIL GRADUATE SCHOOL & RESEARCH SOURCE: Pederg} Reqister, Jupg 18, 1991 (Regq}atioqs effective Augugt 19, 1991) "This document sets forth a common Federal Poliwy for the Protection of Human Subjects accepted by the office of Science aod TacRoology Pollwy and promulgated in regulation by each of the listed Departments and Agencies.• Each of these Departments and Agencies have adopted the common rule as regulations for the protection of human subjects involved in research conducted or funded by the following: Cs Depactzsenc o£ hgu1cu1cure› Dapaztaian€ o£ znecgy; mac1ona1 Aeronautics and Spaoe Adm£n1e€cac1ozt› Dapaz-haiarzc oC Coaaaocce; Conauaiou product Sa£ecy Cozam1ee ton; InVecna€1one1 Deva1ogxaan€ Coopora¢1oa kgency; urgency Com IncecnahLonaL Deea1o$man€; Depactaian€ of Bous1ng aztd Ocban Davalogaaanc; Depaccmenc o£ 6uac1ce› Depaz-ba›nnc oC De£anee; Depaz€a›anc o£ 6duoac1on; Depaz-beanjr o£ ve€aran ACCa1ce; 8ecc1on for g'o abas doea fib1a po11oy app1g's (a) . . . this policy applies to all research involving human subjects conducted, supported or otherwise subject to regulation by any federal department or agency which takes appropriate administrative action to make the policy applicable to such research. . . . It also includes research conducted, supported, or otherwise subject to regulation by the federal government outside the United States. (2) Research that is neither conducted nor supported by a federal department or agensy but is subject to regulation as defined in Section 102(e) must be reviewed and approved, in compliance with Sections 101,102, ana rod through 117 Of this policy, by an institutional review board (IRB) that operates in accordance witA the pertinent requirements of this policy. 1.18 Børtør (Witb Patitøts or Oients) splay (Warse Staødøxii 1•I7. bluliipi» Refer-i- llTAirŁPsüyRaąuaBorS iæ certification is not submitted within these time limits, the application or proposal may be returned to the institution. (Approved by the Office of Hanagement and Budget under Control Nuatbec 9999-O02 0. ) 8ac21one xo4 •arougb 106 [Reaez-vedj Backlog 1o7 ZRB aaabexsb1p a) Each IRB shall have at least five members, with varying backgrounds to promote complete and adequate review of research activities commonly conducted by tRe institution. In addition to possessing the professional competence necessary to review specific research activities, the IRB shall be able to ascertain the acceptability of proposed research in terms of institutional commitments and regulations, applicable law, and standards of professional conduct and practice. b) Every nondiscriminatory effort will be made to ensure that no IRB consists entirely of men or entirely of women. c) Each IRB ehall include at least one member whose primary concerns are in scientific areas and at least one member whose primary concerns are in nonscientific areas. d) Each IRB shall include at least one msmbsr who is not otherwise affiliated with the institution and who is not part of the immediate #amily of a person who is affiliated with the institution. e) NO ORB may have a member participate in review of any project in whicA the membsr has a conflicting interest, except to provide information. f) An IRB may, in its discretion, invite individuals with eompetence in special areas to assist in the review of issues which require expertise beyond or in addition to that available on the IRB. These individuals say not vote with the IRB. 8ec€1oa 1os IeB €uac€1ona and opeg a €1ons. Each IRB shall: a) POllow written procedures; b) Rxcep£ when an expedieed review procedure in used review proposed research at convened meetings at which a majority of the members of the IRB are present, including at lease one member whose primary concerns are in nonscientific areas. In order for the research to be approved, it shall receive the approval of a majority of those members present at the meeting. 5 Section 109 IRB Review of Research. a) An IRB shall review and have authority to approve, require modifications in (to secure approval), or disapprove all research activities. b) An IRB shall require that information given to subjects as part of informed consent is in accordance with Section.116. The IRB may require that information, in addition to that specifically mentioned in Section.116, be given to the subjects when in the IRB's judgment the information would meaningfully add to the protection of the rights and welfare of subjects. c) An IRB shall require documentation of informed consent. d) An IRB shall notify investigators and the institution in writing of its decision to approve or disapprove the proposed research activity, or of modifications required to secure IRB approval of the research activity. e) An IRB shall conduct continuing review of research covered by this policy at intervals appropriate to the degree of risk, but nOt less than once per year, and shall have authority to observe or have a third party observe the consent process and the research. 8ec€1on 11O Bs$seé1•ad z'•e1ew' pgocaduzeg fog' m €a1O 3c1odo of zogeaacb fgsoo1a1ag no aoaa Oban a1a3ma1 g'1o$t, aoQ Coz' a1zzot cbaBgeo a) In the Federal Register, a list of categories of research that may be reviewed by the IRB through an expedited review procedure will be amended, as appropriate after consultation with other departments and agencies. b) An IRB may use the expedited review procedure to review 1. Some or all of the research appearing on the list and found by the reviewer(s) to involve no more than minimal risk. 2. Minor changes in previously approved research. Under an expedited review procedure, the review may be carried out by the IRB chairperson or by one or more experienced reviewers designated by the chairperson. Reviewers may exercise all of the authorities of the IRB except that the reviewersmay not disapprove the research• a) To approve research covered by this policy the IRB shall determine that all of the following requirements are satisfied: 1 • Risks to subjects are minimized. 2. Risks to subjects are reasonable in relation to anticipated benefits. The IRB should not consider possible long-range effects of applying knowledge gained in The research (foe example, the peesible effecrt:s og I:he research on public policy) as among thoae research risks that fall within the purview of its responsibility. 3. Selection of subjects is equitable. 4. Informed consent will be sought from each prospsctive subject or the subject's legally authorized. 5. Informed consent will be appropriately documented. 6. When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects. 7. There are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, pregnant women, mentally disabled persona, or econoaicallY or educationally disadvantaged persons, additional safeguards have been included in the study to protect tAe rights and welfare of tRese subjects. Research covered by this policy that has been approved by ah IRB may be subject to further appropriate review by officials of the institution. 8•C*1O» 113 6UfipaO81OO or ¢eza1:aa61on OC Zea &ppg'Ova1. An IRB shall have autAoritY to suspend or terminate approval of research that is not being conducted in accordance with the IRB's requirements or that has been associated witA unexpected serious harm to subjects. Bec21oo 114 coopaxa€1ve Raseacaa. Cooperative research projects are those projects covered by this policy which involve more than one institution. In the conduct of cooperative research projects, each institution is responsible for safeguarding the rights and welfare of husmn subjects and for complying with this policy. An institution participating in a cooperative project may enter into a joint review arrangement, rely upon the review of another qualified ZRB, or nake similar arrangement:a for avoi‹:ling duplication of effort. sactioo us zRe xecora•. An IRB, shall prepare and maintain adequate documentation of IRB activities, including the following: 1. Copies of all research proposals reviewed. 2. of IRB meetings s. Records of continuing review activities. 4. Copies of all correspondence. 5. A list of IRB members. 6. Writ:I:en procedures for the ZRB . An investigator shall seeE such consent only under circumstances that provide the prospective subject or the representative sufficient opportunity to consider whether or not to participate and that minimize the possibility of coercion or undue influence. The information that is given to the subject or the representative shall be in language understandable to the subject or the representative. a) Basic elements of informed consent 1. A statement that the study involves research, an explanation of the purposes of the research and the expected duratiOn of the subject's participation, a description of the procedures to be followed, and identification of any procedures which are experimental, 2. A description of any reasonably foreseeable risks or discomforts to the subject, 3 . A description of any benefits to the subject or to others which may reasonably bm expected from the research; 4. A disclosure of appropriate alternative procedures or courses of treatment, if any; 5. & statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained; 6. An explanation as to whether any compensation and an explanatioñ as to whether any medical treatments are available lf injury occura and, if so, what they consist of, or where further information xay be obtained, 7. An explanation of whom to contact for answers to pertinent questions; 8. A statement that participati on is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject say discontinue participation at any time. b) When appropriate, one or more of the following elements of information shall also be provided to each subject: 1. L statement that the particular treatment or procedure may involve rieks; 2. Anticipated circumstances under which the subject's participation may be terminated; 3. Any additional costs tO the subject; 4. TAe consequences of a subject's decision to withdraw. 8ectie# 117. Documantatio# of Informed consent, a) Informed consent shall be documented by the use of written consent form approved by the IRB and signed by the subject or the subject's legally authorized representative. A copy shall be given to the person signing the form. ) ° -Y waive the requirement for the investigator to obtain a signed consent form for some or all subjects if it finds either: 1. That the only record linking the subject and the research would be tAe consent document and the principal risk would be potential harm resulting from a breach of confidentiality. 2. That the research presents no more tAan minimal risk of harm to subjects and involves no procedures for which written consent is normally required. 8ec€1oa 118 kpp11caC1oss aod puopoaala 1acjc:Log QeI1o12e p1aaa gon 1aooloamaaC g£ aua a •ubJec2fi• In the event research is undertaken without the intention of involving human subjects, but it is later proposed to involve human suh3eHs In the researcht I:he research afraid fl.ref be reviewed and approved by an IRB, as provided In this policy. Bec€1oa 120 Bea1ua61•a aaA d1apoa1€1on pcoposala €ou xeeaazcb •o b• coaauc•e4 The department or agency head will evaluate all applications and proposals involving human subjects submitted to the department or agency 8ac€1oa 121 [Reserved] seoa£on xzz Ose o€ s•d•xa1 €uo4a. Pederal funds administered by a department or agency may not be 4zpendmd for research involving human subjects unless the requirements of this policy have been satisYiud. Bacg1oa 123 Bnz'1g' €•zmñDab1oO of z'eaaag'cb guppozfi I Bva1tza€1oo oC app11oaC1oaa aod pxopoaals. a) The department or agency head nay require that department or agency support for any project to be terminated or suspended when the department or agency head Sinds an institution has materially failed to comply with the terms of this policy. sa«g1oa 12« cooa181o¥ta1 Zae appg'o 1. The department or agency head may impose additional conditions prior to or at the time of approval when in the judgment of the department or agency head additional conditions are necessary. 10 t estimony recommyyding changes to Bill 347 Profsof Smiology and Commuiñty De*el°i*i&t College of Agriculture & Life Scit•-, U£Ki Greetings to Senator Kasperbauer, members of the Committee On Education, and other attendees to today’s Public Hearing. I speak on the subject of Bill 347 drawing from my experience of 20 years conducting research involving human subjects on Guam and in Micronesia, and my tenure with the University’s Committee on I-luman Research Subjects since it’s inception in 1982. I strongly support the intent of Bill 347 that any research study involving the participation of citizens and residents of Guam should be required to have at least one review by an appropriately constituted institutional review board established on Guam Scientific research has produced substantial social benefits, yet has also posed some troubling ethical queitions. Since 1945, various codes for the proper and responsible conduct of human experimentation in medical research hsve been adopted. Basic principles of research involving human subjects developed by these codes have been summarized in the Belmont Report, by The National Commission for the Protection of Human Subjects of Biomedical & Behavioral Research, U.S. Department of Health, Education and Welfare (Published: April 18, 1979). I note this an‹ attach a summary of it for you to clarify the ethical issues inherent in research involving human subjects. The essential heart of concern is Respect for Persons: the idea that individuals are capable of deliberation about personal goals and of acting under the direction of such deliberation. To respect autonomy is to give weight to a persons’ considered opinions and choices. To show lack of respect for an autonomous agent is to deny an individual the freedom to ad on those considered judgements, or to withhold information necessary to make a considered judgement Respect for persons demands that subjects enter into the research voluntarily and with adequate information. Applications of the general principles to the conduct of research leads to consideration of the following requirements: 1. I o ed C t: requires that subjects, to the degree that they are capable, be given the opportunity to choose what shall or shall not happen to them, and 2. Aices e o presents both an opportunity and a responsibility. Many kinds of possible harms and benefits need to be taken into account. There are, for example, risks of psychological harm, physical harm, legal harm, social harm and economic harm and the corresponding benefits. Risk can perhaps never be entirely eliminated, but it can often be reduced by careful attention to alternative procedures. The University of Guam’s Human Research Subjects Committee, an irb meeting the appropriate federal guidelines, has more than adequately carried out this responsibility for research involving or associated with UOG faculty or students. I have attached a copy of their guidelines to investigators. In recent years and with the assistance of UOG faculty the Guam Memorial Hospital has established a similar irb for research within its facility, or in association with its personnel and medical staA The purpose is to comply with federal regulation for grant funding: SOURCE- Federal Register June l8. 199} (ReguÍations effective Aupust I9. 1991j Secfion 103 Assuring compliance with this policy-research conducted or supported by any federal department or agency. (a) Each institution engaged in resmrch which is covered by this policy and which is conducted or supported by a federal department or agency shall provide written assurance satisfactory to the department or agency head that it will comply with the requéements sa forth in this policy. In lieu of requiring submission of an assurance, appropriate for the resmrch in question, on tile with the 0&ce for Protection om Re